Vamsi Labs Ltd. is a globally recognized Active Pharmaceutical Ingredient (API) manufacturer with over 30 years of expertise, specializing in respiratory APIs, particularly COPD therapies and corticosteroids. The company operates US FDA and EU-GMP compliant facilities, serving customers across regulated markets worldwide.

Vamsi Labs offers integrated CDMO services, supporting partners across the entire drug substance lifecycle—from R&D and process development to pilot-scale and commercial manufacturing. Its strong process chemistry capabilities enable efficient scale-up of complex molecules with a focus on quality, cost optimization, and supply reliability.

A key differentiator is its in-house micronization and particle size engineering division, critical for inhalation products, combined with advanced analytical capabilities that support inhalation-specific testing and regulatory requirements.

The company has a robust global regulatory presence with 9 US DMFs, 12 CEPs, and 10 Chinese IDL registrations, along with product registrations in over 55 countries.

With a strong focus on innovation, compliance, and long-term partnerships, Vamsi Labs is a trusted partner for global pharmaceutical companies seeking reliable, end-to-end API and CDMO solutions in the respiratory space.